BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9716603)

  • 21. ZNF198, a zinc finger protein rearranged in myeloproliferative disease, localizes to the PML nuclear bodies and interacts with SUMO-1 and PML.
    Kunapuli P; Kasyapa CS; Chin SF; Caldas C; Cowell JK
    Exp Cell Res; 2006 Nov; 312(19):3739-51. PubMed ID: 17027752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular monitoring of 8p11 myeloproliferative syndrome in an infant.
    Zhang WW; Habeebu S; Sheehan AM; Naeem R; Hernandez VS; Dreyer ZE; López-Terrada D
    J Pediatr Hematol Oncol; 2009 Nov; 31(11):879-83. PubMed ID: 19829149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The t(8;13) atypical myeloproliferative disorder: further analysis of the ZNF198 gene and lack of evidence for multiple genes disrupted on chromosome 13.
    Still IH; Cowell JK
    Blood; 1998 Aug; 92(4):1456-8. PubMed ID: 9694738
    [No Abstract]   [Full Text] [Related]  

  • 24. t(6;8), t(8;9) and t(8;13) translocations associated with stem cell myeloproliferative disorders have close or identical breakpoints in chromosome region 8p11-12.
    Chaffanet M; Popovici C; Leroux D; Jacrot M; Adélaïde J; Dastugue N; Grégoire MJ; Hagemeijer A; Lafage-Pochitaloff M; Birnbaum D; Pébusque MJ
    Oncogene; 1998 Feb; 16(7):945-9. PubMed ID: 9484786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Critical role of STAT5 activation in transformation mediated by ZNF198-FGFR1.
    Heath C; Cross NC
    J Biol Chem; 2004 Feb; 279(8):6666-73. PubMed ID: 14660670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ZNF198-FGFR1 transforms Ba/F3 cells to growth factor independence and results in high level tyrosine phosphorylation of STATS 1 and 5.
    Smedley D; Demiroglu A; Abdul-Rauf M; Heath C; Cooper C; Shipley J; Cross NC
    Neoplasia; 1999 Oct; 1(4):349-55. PubMed ID: 10935490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The 8p11 myeloproliferative syndrome].
    Reither A; Hehlmann R; Goldman JM; Cross NC
    Med Klin (Munich); 1999 Apr; 94(4):207-10. PubMed ID: 10373756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The t(8;17)(p11;q23) in the 8p11 myeloproliferative syndrome fuses MYO18A to FGFR1.
    Walz C; Chase A; Schoch C; Weisser A; Schlegel F; Hochhaus A; Fuchs R; Schmitt-Gräff A; Hehlmann R; Cross NC; Reiter A
    Leukemia; 2005 Jun; 19(6):1005-9. PubMed ID: 15800673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ZNF198 protein, involved in rearrangement in myeloproliferative disease, forms complexes with the DNA repair-associated HHR6A/6B and RAD18 proteins.
    Kunapuli P; Somerville R; Still IH; Cowell JK
    Oncogene; 2003 May; 22(22):3417-23. PubMed ID: 12776193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The 8p11 myeloproliferative syndrome: review of literature and an illustrative case report.
    Goradia A; Bayerl M; Cornfield D
    Int J Clin Exp Pathol; 2008 Jan; 1(5):448-56. PubMed ID: 18787627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase.
    Montenegro-Garreaud X; Miranda RN; Reynolds A; Tang G; Wang SA; Yabe M; Wang W; Fang L; Bueso-Ramos CE; Lin P; Medeiros LJ; Lu X
    Hum Pathol; 2017 Jul; 65():147-156. PubMed ID: 28551329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endogenous retroviral sequence is fused to FGFR1 kinase in the 8p12 stem-cell myeloproliferative disorder with t(8;19)(p12;q13.3).
    Guasch G; Popovici C; Mugneret F; Chaffanet M; Pontarotti P; Birnbaum D; Pébusque MJ
    Blood; 2003 Jan; 101(1):286-8. PubMed ID: 12393597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The t(1;9)(p34;q34) and t(8;12)(p11;q15) fuse pre-mRNA processing proteins SFPQ (PSF) and CPSF6 to ABL and FGFR1.
    Hidalgo-Curtis C; Chase A; Drachenberg M; Roberts MW; Finkelstein JZ; Mould S; Oscier D; Cross NC; Grand FH
    Genes Chromosomes Cancer; 2008 May; 47(5):379-85. PubMed ID: 18205209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Localization of the 8;13 translocation breakpoint associated with myeloproliferative disease to a 1.5 Mbp region of chromosome 13.
    Kempski H; MacDonald D; Michalski AJ; Roberts T; Goldman JM; Cross NC; Cowell JK
    Genes Chromosomes Cancer; 1995 Apr; 12(4):283-7. PubMed ID: 7539283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myeloproliferative disorders with t(8;9)(p12;q33): a case report and review of the literature.
    Hu S; He Y; Zhu X; Li J; He H
    Pediatr Hematol Oncol; 2011 Mar; 28(2):140-6. PubMed ID: 21214407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of the plasminogen activator inhibitor-2 in cells expressing the ZNF198/FGFR1 fusion kinase that is involved in atypical myeloproliferative disease.
    Kasyapa CS; Kunapuli P; Hawthorn L; Cowell JK
    Blood; 2006 May; 107(9):3693-9. PubMed ID: 16410451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B-lymphoblastic leukemia/lymphoma associated with t(8;13)(p11;q12)/ ZMYM2 (ZNF198)-FGFR1 : rare case and review of the literature.
    Trimaldi J; Carballido EM; Bowers JW; Anguiano AL; Zhang ZJ; Shah BD; Bruno S; List AF; Moscinski LC; Grady T; Agosti SJ; Kang L; Zhang L
    Acta Haematol; 2013; 130(3):127-34. PubMed ID: 23594707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ZNF198-FGFR1 transforming activity depends on a novel proline-rich ZNF198 oligomerization domain.
    Xiao S; McCarthy JG; Aster JC; Fletcher JA
    Blood; 2000 Jul; 96(2):699-704. PubMed ID: 10887137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [FGFR1 and MOZ, two key genes involved in malignant hemopathies linked to rearrangements within the chromosomal region 8p11-12].
    Pébusque MJ; Chaffanet M; Popovici C; Birnbaum D
    Bull Cancer; 2000 Dec; 87(12):887-94. PubMed ID: 11174118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical pathological features of the 8p11 myeloproliferative syndrome].
    Yan Z; Yang B; Wang QS; Wang LL; Han XP; Ren F; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1321-6. PubMed ID: 21129285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.